Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

von Hippel-Lindau Disease × Vorinostat × 90 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lung Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

belzutifan 2 Everolimus 2 spartalizumab 1 palbociclib 1 lenvatinib 1 gallium Ga 68 dotatate 1 cabozantinib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡